India's Cadila to end late-stage trials of potential COVID-19 vaccine in March

India's Zydus Cadila plans to complete late-stage trials for its potential coronavirus vaccine in March 2021 and could produce up to 100 million doses a year if trials are successful, Chairman Pankaj Patel told Reuters.

from bdnews24.com - Home https://ift.tt/32se9Og